FIELD: medicine.
SUBSTANCE: declared group of inventions refers to the veterinary science and is applicable for treating a subclinical form caused by PCV2 infection in animals. There are declared a method of treating the subclinical form of PCV2 infection; a method of reducing a growth disorder caused by the subclinical form of PCV2 infection; a method of reducing a quantity of animals with viral load exceeding 106 genome copies per one ml of serum; a method of reducing virus isolation from a nose and//or a length of viraemia in animals infected with the subclinical form of PCV2. The declared methods involve the stage of administering a therapeutically effective amount of OFR-2 protein of PCV2 into an animal in need thereof. The subclinical form of PCV2 infection is characterised by the virus load in a body of an individual animal less than 106 genome copies of PCV2 per one ml of the serum. What is also declared is using the OFR-2 protein of PCV2 for preparing a drug for implementing the declared methods.
EFFECT: declared group of inventions is high effective for treating the subclinical form of animal's PCV2 infection.
24 cl, 5 dwg, 3 tbl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
RELIEVING CONCURRENT INFECTIONS IN PIGS USING PCV2 ANTIGEN | 2008 |
|
RU2491092C2 |
TREATING PRDC IN GILTS | 2008 |
|
RU2522849C2 |
TREATMENT OF PIGS WITH PCV2 ANTIGEN | 2007 |
|
RU2520087C2 |
PCV2B DIVERGENT VACCINE COMPOSITION AND METHODS OF USE | 2014 |
|
RU2662685C2 |
IMMUNOGENIC COMPOSITIONS FOR IMMUNIZATION OF PIGS AGAINST CIRCOVIRUS TYPE 3 AND METHODS OF PRDUCTION AND APPLICATION THEREOF | 2016 |
|
RU2744193C2 |
PORCINE CIRCOVIRUS TYPE 3 (PCV3) VACCINES, PRODUCTION AND USE THEREOF | 2020 |
|
RU2813989C2 |
MULTIVALENT IMMUNOGENIC COMPOSITIONS PCV2 AND METHODS FOR PRODUCING THESE COMPOSITIONS | 2006 |
|
RU2577129C2 |
METHODS AND COMPOSITIONS FOR IMMUNISATION OF PIGS AGAINST PORCINE CIRCOVIRUS | 2008 |
|
RU2493254C9 |
IMMUNOGENIC COMPOSITIONS FOR IMMUNIZATION OF PIGS AGAINST TYPE 3 CIRCOVIRUS AND METHODS OF THEIR PRODUCTION AND USE | 2022 |
|
RU2803427C1 |
COMBINED VACCINE PCV/MYCOPLASMA HYOPNEUMONIAE | 2013 |
|
RU2615443C2 |
Authors
Dates
2014-06-27—Published
2008-02-11—Filed